Ingevity (NGVT) Capital Expenditures (2016 - 2025)
Ingevity (NGVT) has disclosed Capital Expenditures for 11 consecutive years, with $23.6 million as the latest value for Q4 2025.
- Quarterly Capital Expenditures fell 68.7% to $23.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $70.5 million through Dec 2025, down 9.15% year-over-year, with the annual reading at $57.7 million for FY2025, 25.64% down from the prior year.
- Capital Expenditures for Q4 2025 was $23.6 million at Ingevity, down from $31.8 million in the prior quarter.
- The five-year high for Capital Expenditures was $103.7 million in Q4 2023, with the low at -$57.0 million in Q4 2021.
- Average Capital Expenditures over 5 years is $13.6 million, with a median of $8.8 million recorded in 2022.
- The sharpest move saw Capital Expenditures soared 51950.0% in 2023, then tumbled 4162.5% in 2024.
- Over 5 years, Capital Expenditures stood at -$57.0 million in 2021, then surged by 99.65% to -$200000.0 in 2022, then skyrocketed by 51950.0% to $103.7 million in 2023, then fell by 27.29% to $75.4 million in 2024, then plummeted by 68.7% to $23.6 million in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods came in at $23.6 million, $31.8 million, and $12.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.